Barely Significant
← all excerpts

In search of clinically relevant parameters to monitor successful omalizumab therapy in allergic asthma.

Allergol Select · 2018 · PMC6881860 · PMID 31826042

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantp < 0.001actually significant
Under omalizumab therapy, a highly significant reduction of airway resistance (p < 0.001) was observed in responders as compared to non-responders.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.